Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Assess historical performance and potential in retirement for SP500 and Total Market funds, focusing on consistency and drawdown behavior.
28,444 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
When the carradine family breaks hollywood, they show how openness can shape finances and future planning. This artic...
Planning to use leveraged exposure to the S&P 500? This guide compares SPXL and SSO, explaining how each ETF magnifie...
Oil tensions linked to Iran have put pressure on stocks, lifting energy prices and weighing on the S&P 500 and Nasdaq...
As driverless taxis move from test zones to real streets, Alphabet and its Waymo unit sit at the center of the race. ...
If you’re looking for a steadier way to grow wealth over the long term, bank stock can be part of the answer. This gu...
A new AP-NORC poll shows growing doubt about the American Dream as the nation approaches its 250th birthday, with you...
May's inflation outlook from the Federal Reserve hints at bigger moves for markets. This guide explains what that mea...
Two popular ETFs vie for attention in growth-heavy markets. This guide breaks down what each fund owns, how they beha...
An Axcelis VP Corporate Controller sold 2,574 shares for roughly $422k. This article breaks down what that means, how...
What counts as the ultimate “stress test” for housing in 2026? This article breaks down signals, scenarios, and pract...
A landmark reading shows the market cap to GDP ratio at an all-time high. This article breaks down what that means, w...